Neoceuticals Limited was formed in 2005 by its co-founders
Dr. Andrew Brodrick and Dr. Rod Adams are highly experienced Pharmaceutical Executives and have an outstanding reputation for innovation and providing solutions for healthcare professionals.
Although set up to primarily serve the UK market, Neoceuticals' product range is gaining traction worldwide with an expanding export portfolio. The company is actively seeking partners in a number of other overseas markets to help facilitate the company's continued growth.
September 6th
2021, marks an important milestone for Neoceuticals. Guangxi Minglei Weisheng Pharmaceutical Co. Ltd, a Chinese pharmaceutical company acquired 100% equity of the company with an ambition to strengthen new drug research and development, and expand its global business.
